Application 209050
- Type
- ANDA
- Sponsor
- YABAO PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SORAFENIB TOSYLATE | SORAFENIB TOSYLATE | TABLET;ORAL | EQ 200MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24979-715 | Sorafenib | Sorafenib | TWi Pharmaceuticals USA, Inc. | ANDA | Current |
| 24979-715 | sorafenib | sorafenib | TWi Pharmaceuticals USA, Inc. | ANDA | Current |
| 51990-201 | Sorafenib | Sorafenib | Yabao Pharmaceutical Co., Ltd. Beijing | ANDA | Current |